Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
10.95M | 7.80M | 30.49M | 49.03M | 12.38M | 3.40M | Gross Profit |
-47.27K | 2.17M | 10.20M | 21.03M | 2.99M | 1.49M | EBIT |
-6.13M | -5.80M | -2.30M | 23.63M | -4.26M | -4.01M | EBITDA |
-16.09M | -6.95M | -13.46M | 13.29M | -3.52M | -2.45M | Net Income Common Stockholders |
-20.13M | -19.14M | -17.26M | 9.09M | -5.01M | -2.78M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
654.63K | 1.13M | 9.41M | 17.99M | 1.97M | 119.67K | Total Assets |
9.32M | 12.71M | 36.00M | 42.64M | 10.00M | 7.91M | Total Debt |
440.23K | 5.19M | 4.53M | 253.77K | 518.58K | 449.82K | Net Debt |
-214.40K | 4.85M | -4.41M | -15.15M | -1.45M | 330.15K | Total Liabilities |
4.95M | 11.70M | 13.23M | 10.15M | 6.75M | 5.00M | Stockholders Equity |
4.37M | 1.00M | 22.77M | 32.49M | 3.25M | 2.91M |
Cash Flow | Free Cash Flow | ||||
-3.56M | -6.94M | -2.28M | 11.42M | -611.50K | -1.23M | Operating Cash Flow |
-3.45M | -5.62M | -249.09K | 11.45M | -595.10K | -1.18M | Investing Cash Flow |
647.56K | -969.15K | -3.79M | -234.41K | -14.93K | -300.03K | Financing Cash Flow |
1.93M | -254.18K | -2.40M | 2.19M | 2.48M | 967.41K |
Datametrex AI Limited has signed a non-binding Letter of Intent to acquire Arbutus Health and Wellness Inc., a multidisciplinary medical clinic in Vancouver, for up to $1.1 million through common shares. This strategic acquisition aims to expand Datametrex’s healthcare business, strengthen its sector presence, and align with its long-term growth strategy. Additionally, Richard Yoon has resigned from the Board of Directors, and the company is in the process of identifying a suitable replacement.
Datametrex AI Limited has announced a strategic plan to focus on its healthcare and AI businesses by expanding clinic operations and strengthening AI services. The company plans to acquire additional clinics, wind down non-core businesses, and split into two entities to enhance operational efficiency and shareholder value.
Datametrex AI Limited has announced the effective date for its share consolidation, where its common shares will begin trading on a consolidated basis of one post-consolidation share for every thirty pre-consolidation shares on the TSX Venture Exchange. This move will adjust the total issued and outstanding number of shares to approximately 21,002,671, potentially impacting the company’s market dynamics and investor relations.
Datametrex AI Limited announced a proposed consolidation of its common shares, aiming to optimize the capital structure and attract financing. The consolidation will change the share ratio to one new share for every thirty existing shares, reducing the number of shares from 630,080,158 to 21,002,671, subject to regulatory approval. This move is expected to impact the company’s operations by potentially improving its financial flexibility and attractiveness to investors.
Datametrex AI Limited announced that its subsidiary, Datametrex Korea, has received purchase orders valued at approximately $1.1 million for service and tech support, with a projected gross profit margin of 63%. This achievement highlights the company’s ongoing financial growth and its dedication to strengthening client partnerships and expanding its industry presence.
Datametrex AI Limited, through its subsidiary Datametrex Korea, has secured a new purchase order worth approximately $440,000, with an expected gross profit margin of 33%. This order underscores the company’s robust position in the IT industry, bolstered by its effective ‘land and expand’ strategy and strong partnerships with existing clients. The announcement reflects Datametrex’s commitment to innovation and delivering long-term value, reinforcing its growth trajectory in the AI and tech sectors.